|
| ID |
DDInter51 |
| Drug Type |
small molecule |
| Molecular Formula |
C18H21N5O2 |
| Molecular Weight |
339.399
|
| Description |
Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus.
|
| ATC Classification |
A10BD13
A10BD09
A10BH04
|
| IUPAC Name |
2-({6-[(3R)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-1,2,3,4-Tetrahydropyrimidin-1-Yl}Methyl)Benzonitrile |
| InChI |
Inchi=1S/C18H21N5O2/C1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/H2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/T15-/M1/S1 |
| InChI Key |
ZSBOMTDTBDDKMP-OAHLLOKOSA-N |
| Canonical SMILES |
CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O |
| Useful Links |
DrugBank
ChEMBL
PubChem
|